Evidence map›Paper›PMID 41286987›Full record

ArticleJournal of medical case reports2025

Secondary ocular syphilis in an immunocompromised patient: a case report.

Richard Farnan, Hamid Nafees, Gordon Farnan, Maedbh Rhatigan

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Richard FarnanUniversity Hospital Galway, Newcastle Road, Galway, Republic of Ireland. farnanr@tcd.ie.
Hamid NafeesUniversity Hospital Galway, Newcastle Road, Galway, Republic of Ireland.
Gordon FarnanUniversity Hospital Galway, Newcastle Road, Galway, Republic of Ireland.
Maedbh RhatiganUniversity Hospital Galway, Newcastle Road, Galway, Republic of Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOcular syphilis is an uncommon but important complication of syphilis, most often presenting as posterior or panuveitis in latent syphilis of unknown duration. If left untreated, ocular syphilis can result in permanent vision loss, which underscores the importance of appropriate evaluation and treatment of ocular syphilis. CASE PRESENTATION: A unique case, involving a 32-year-old Irish man who presented with sudden-onset deterioration in his right-sided visual acuity, is presented. This man reported significant deterioration in his right-sided visual acuity from a previous baseline of 6/6 vision to "counting fingers." His ophthalmic history was unremarkable up until that event, but his medical history encompassed psoriatic arthritis, managed by sustained monoclonal antibody therapy in the form of adalimumab. CLINICAL

findingsThe clinical findings at initial presentation included painless monocular right-sided visual loss with gradual onset and discomfort associated with active eye movement alongside frank scalp tenderness. Further examination findings demonstrated a grossly swollen right optic nerve, right-sided visual acuity diminished to "counting fingers" amid normal intraocular pressure measurements. The patient was admitted to hospital and initially managed with intravenous steroid therapy. Subsequent serologic testing revealed an underlying diagnosis of syphilis. Targeted antibiotic therapy was commenced thereafter with further ophthalmic reviews to follow.

conclusionSyphilis may go undetected without a high index of clinical suspicion owing to its often nonspecific presentation. All patients with ocular inflammation should have syphilis testing as a part of their infectious workup with both treponemal and nontreponemal testing.

Indexed as

Eye Infections, BacterialImmunocompromised HostSyphilisAdalimumabAdultAnti-Bacterial AgentsHumansMaleVision DisordersVisual AcuityAdalimumabAnti-Bacterial AgentsMonoclonal antibodyOcular syphilisSteroids

Identifiers

PMID41286987
PMCPMC12641976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.